VMP 41879011000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Medroxyprogesterone 10mg tablets
BNF code 0604012M0AAAEAE
Virtual Therapeutic Moiety Medroxyprogesterone
Date identifier became valid 26 May 2023
Previous product identifier 325601006
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Medroxyprogesterone acetate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Provera 10mg tablets (CST Pharma Ltd)
Provera 10mg tablets (Lexon (UK) Ltd)
Provera 10mg tablets (Necessity Supplies Ltd)
Provera 10mg tablets (Pfizer Ltd)
Provera 10mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Medroxyprogesterone 10mg tablets 100 tablet
Medroxyprogesterone 10mg tablets 10 tablet
Medroxyprogesterone 10mg tablets 30 tablet
Medroxyprogesterone 10mg tablets 90 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.

Feedback